Biomanufacturing of a New Class of Protein Therapeutic and Use to Block Neutralizing Antibodies that Otherwise Inactivate the Gene Therapy Delivery Vehicle
NCBiotech Grants & Loans
See the full listing of all NCBiotech grants and loans awarded since July 2012.
Organization
NabGen, Inc.
Award Date
Award Amount
250,000
Program Name
Small Business Research Loan
Program Category
Business Financing
Principal Investigator
Charles Askew
Fiscal Year
2021
Region
Research Triangle
Project Description:
NabGen, Inc. has developed a technology (“Neutralizing Antibody Escape Platform”) to transiently “block” neutralizing antibodies that can impede the effectiveness of gene therapies. The company was awarded a $250k SRL to support development of a scalable biomanufacturing process and pilot production of the Company’s molecules.